 |
4th Annual Drug Discovery:
Easing The Bottleneck |
| |
| October, 2012 |
| Boston, MA |
| |
|
|
| |
|
|
|
 |
|
| |
Our Drug Discovery series continues with our 4th Annual Drug Discovery: Easing The Bottleneck conference.
The production of new drugs has always been paramount for pharmaceutical manufacturers, but with key patents now expiring, cost effective drug discovery is more important than ever. This event will bring together the foremost experts on compound management, gene expression, and other pertinent areas to the drug discovery process. Through targeted panel discussion our delegates will learn how to improve speed to market, increase profit margins, and most importantly; develop new and live saving drugs and biotechnology!
|
Hot topics of discussion to include:
- The New Landscape: Drug Discovery in an Age of Mergers, Acquisitions and Innovation
- Narrowing the Interface Between Lead Discovery and Optimization
- Strategic Business Spotlight: Outsourcing Internationally
- Biologics: The New Frontier of Drug Discovery
- Utilizing In-Vitro Data to Augment In-Vivo Predictions
- The Role of IT in Fighting Drug Discovery Bottlenecks
Join us for 2 days of panels, presentations, workshops and more! |
| |
|
|
| |
| Opal Events' 4th Annual Drug Discovery: Easing the Bottleneck 2011 conference has been researched and developed specifically for; Pharmaceuticals, Biotech, Academia, Foundation, Technology Companies, and CROs' VP/ Director/ Manager/ Faculty Advisor of: |
| |
• External Research Collaboration
• Scientific Affairs
• Business Development
• Partnership/ Alliance Management
• Office of Technology Transfer
• Academic Screening Facilities
• School of Medicine/ Life Sciences/ Pharmacy
• Grants Manager
• Program Office |
• Research & Development
• Analytical/ Medicinal Chemistry
• Sample/ Compound Management
• Assay Development
• Lead Discovery/ Optimization
• High Throughput Screening (HTS)
• Automation
• ADMET |
|
| |
| Government officials, compliance officers, individuals from university and research institutes will also find much to benefit from in attending this comprehensive event. |
| |
|
|
| |
- 15+ panels, discussions and presentations of the most relevant, pertinent information to the drug discovery process
- Stimulating discussions on the roles and responsibilities in drug discovery management, as well as new and innovative technologies and strategies
- 5+ hours of scheduled networking opportunities
|
|
|
| |
|
|
| |
Conference Registration Prices: |
|
| |
| |
Early Bird |
Standard |
Service Providers
(including CROs, Legal, Consulting Firms, Vendors, etc.) |
$795 |
$995 |
| * Pharmaceutical Companies - $495 |
|
| |
 |
| |
Group Discounts:
Register 3 people and receive 10% off ***
Register 4 people and receive 15% off ***
Register 5 people or more and receive 20% off *** |
|
***Registrations must be made online on the same date. Discount will be applied after all registrants have been received. |
| |
|
|
If you'd like to be invoiced, please submit your contact details on the registration page and select "Please invoice me" at the bottom of the page.
If you are interested in sponsorship, exhibiting, or speaking opportunities, please call 212-532-9898 or email information@opalevents.org |
|
* TERMS & CONDITIONS
Subject to approval. To qualify you must be currently employed by a non-vendor company. Eligibility will be verified by conference producer. Opal reserves the right to allocate places and to refuse applications. |
|
|
|
| |
 |
| |
| |
